Microparticles engineered to highly express peroxisome proliferator-activated receptor-γ decreased inflammatory mediator production and increased adhesion of recipient monocytes.

by Julie Sahler, Collynn F Woeller, Richard P Phipps
Published 2014-01-01

Proton pump inhibitors attenuate myofibroblast formation associated with thyroid eye disease through the aryl hydrocarbon receptor.

by Christine L Hammond, Elisa Roztocil, Richard P Phipps, Steven E Feldon, Collynn F Woeller
Published 2019-01-01

Salinomycin inhibits proliferative vitreoretinopathy formation in a mouse model.

by Alison M Heffer, Victor Wang, Richard T Libby, Steven E Feldon, Collynn F Woeller, Ajay E Kuriyan
Published 2020-01-01

Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases

by Ajit A. Kulkarni, Collynn F. Woeller, Thomas H. Thatcher, Sesquile Ramon, Richard P. Phipps, Patricia J. Sime
Published 2012-01-01

Discovery of Novel Small Molecules that Block Myofibroblast Formation: Implications for Capsular Contracture Treatment

by Rachel H. Park, BA, Stephen J. Pollock, BSc, Richard P. Phipps, PhD, Howard N. Langstein, MD, Collynn F. Woeller, PhD
Published 2019-09-01

The polyether ionophore salinomycin targets multiple cellular pathways to block proliferative vitreoretinopathy pathology.

by Alison M Heffer, Jacob Proaño, Elisa Roztocil, Richard P Phipps, Steven E Feldon, Krystel R Huxlin, Patricia J Sime, Richard T Libby, Collynn F Woeller, Ajay E Kuriyan
Published 2019-01-01